435PPreliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors. (23rd October 2018) - Boni, V; Garcia-Corbacho, J; Ott, P A; Cho, D C; Autio, K A; Uboha, N; Spira, A I; Humphrey, R; Will, M; Naing, A; Thistlethwaite, F; de Vries, E G E; et al.